WO2025046302 - HYBRID PUNCTAL PLUGS AND METHODS OF USE THEREOF

National phase entry is expected:
Publication Number WO/2025/046302
Publication Date 06.03.2025
International Application No. PCT/IB2024/000477
International Filing Date 28.08.2024
Title **
[English] HYBRID PUNCTAL PLUGS AND METHODS OF USE THEREOF
[French] BOUCHONS MÉATIQUES HYBRIDES ET LEURS PROCÉDÉS D'UTILISATION
Applicants **
EXIMORE LTD.
Inventors
SHEETRIT, Eyal
TOMER, Guy
Priority Data
63/579,363   29.08.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2377
EPO Filing, Examination, Granting14590
Japan Filing, Examination, Granting2315
South Korea Filing, Examination, Granting2449
USA Filing, Examination, Granting6710
MasterCard Visa
Total: 28,441

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The disclosure provides punctal plugs and their method of use for treating ocular diseases or conditions, or symptoms thereof. The punctal plug described here comprises a polymer portion and a composite portion, where the polymer portion is configured to be inserted into a punctum of the eye. An exemplary composite portion of a punctal plug described here comprises at least one active agent, where the active agent is released towards the punctal opening of the eye.[French] L'invention concerne des bouchons méatiques et leur procédé d'utilisation pour le traitement de maladies ou d'affections oculaires, ou de symptômes associés. Le bouchon méatique décrit ici comprend une partie polymère et une partie composite, la partie polymère étant conçue pour être insérée dans un point de l'oeil. Un exemple de partie composite d'un bouchon méatique décrit ici comprend au moins un agent actif, l'agent actif étant libéré vers l'ouverture méatique de l'oeil.

Rejoining the server...